Emergent BioSolutions Q4 Adj. EPS $(0.43) Misses $0.11 Estimate, Sales $148.700M Miss $217.500M Estimate
Benzinga Newsdesk 8 months ago
EarningsEarnings MissesNews
Emergent BioSolutions (NYSE:EBS) reported quarterly losses of $(0.43) per share which missed the analyst consensus estimate of $0.11 by 490.91 percent. This is a 960 percent decrease over earnings of $0.05 per share from
Emergent BioSolutions (NYSE:EBS) reported quarterly losses of $(0.43) per share which missed the analyst consensus estimate of $0.11 by 490.91 percent. This is a 960 percent decrease over earnings of $0.05 per share from the same period last year. The company reported quarterly sales of $148.700 million which missed the analyst consensus estimate of $217.500 million by 31.63 percent. This is a 23.63 percent decrease over sales of $194.700 million the same period last year.